Cytokinetics Inc vs Gemini Space Station Inc — how do they compare? Cytokinetics Inc trades at $76.75 (market cap $10.63B), while Gemini Space Station Inc trades at $4.02 (market cap $512.05M). The key difference: Cytokinetics Inc is far larger — about 20.8× Gemini Space Station Inc's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Gemini Space Station Inc nearer its low. Which is the better fit depends on your goals.
| CYTK | GEMI | |
|---|---|---|
Market Cap | $10.63B | $512.05M |
Sector | Technology | Technology |
52-Week High | $87.26 | $32.52 |
52-Week Low | $34.31 | $3.90 |
Enterprise Value | $10.74B | $502.04M |
Trailing returns across standard periods
Latest headlines on both assets
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →